News Details

Download Document
Hilleman Laboratories signs MoU to fast track development of high-impact Oral Cholera Vaccine
Date: 10/11/2014

Hilleman Laboratories, an equal joint-venture partnership between Merck & Co. and Wellcome Trust, has signed a Memorandum of Understanding (MoU) with Bangladesh-based icddr,b (formerly the International Centre for Diarrheal Disease Research, Bangladesh), an international public health research organization, and Incepta Vaccine Ltd., leading pharmaceutical company in Bangladesh in a bid to fast track the clinical trials and product licensing and commercialization of the product.

sildenafil ratiopharm open sildenafil preis
amoxicillin allergy boomasontennis.com amoxicillin dosage
micardisplus hinta read micardis comp
information on abortions hockey1.com how much is an abortion pill